Arcadia Investment Management’s Novartis NVS Stock Holding History

Arcadia Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-71	Closed	-$6K	–	285
2021 Q2	$6K	Buy	+71	New	+$6.32K	﹤0.01%	274
2018 Q4	–	Sell	-979	Closed	-$76K	–	312
2018 Q3	$76K	Hold	979	–	–	0.02%	185
2018 Q2	$66K	Hold	979	–	–	0.02%	202
2018 Q1	$71K	Hold	979	–	–	0.02%	194
2017 Q4	$74K	Hold	979	–	–	0.02%	191
2017 Q3	$75K	Sell	979 -31	-3%	-$2.34K	0.02%	186
2017 Q2	$76K	Hold	1,010	–	–	0.02%	185
2017 Q1	$67K	Hold	1,010	–	–	0.02%	190
2016 Q4	$66K	Buy	1,010 +804	+390%	+$52.2K	0.02%	188
2016 Q3	$15K	Hold	206	–	–	0.01%	287
2016 Q2	$15K	Hold	206	–	–	﹤0.01%	374
2016 Q1	$13K	Buy	206 +31	+18%	+$2.11K	﹤0.01%	246
2015 Q4	$14K	Buy	+175	New	+$13.9K	﹤0.01%	247

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Arcadia Investment Management's NVS Position: Q3 2021 in Review

Arcadia Investment Management sold out of Novartis (NVS) in Q3 2021, closing a stake of 71 shares — an estimated $6K sold.

Arcadia Investment Management first reported a position in NVS in Q4 2015 and held it in 13 quarters. The position peaked at $76K in Q3 2018. 1,080 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

Arcadia Investment Management reported no remaining Novartis position as of Q3 2021 after selling out during the quarter.
Arcadia Investment Management sold 71 Novartis shares in Q3 2021, an estimated $6K.
Arcadia Investment Management first reported a position in Novartis in Q4 2015 and held it in 13 quarters.
Arcadia Investment Management's Novartis position peaked at $76K in Q3 2018.
1,080 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Arcadia Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.